Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Chronic Kidney Disease; This is a spontaneous report received from a Consumer or other non HCP, Program ID. An elderly female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in 2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHRONIC KIDNEY DISEASE (medically significant), outcome "not recovered". Clinical course: The patient mentioned that she now has Chronic Kidney Disease and an uncertain but slight suspicion that this could have been a result of COVID-19 vaccination, although she recognized this was unlikely. Her last COVID-19 vaccine she thinks was in 2023. The specific vaccine manufacturer was unknown but it is possible/suspected that it could have been Comirnaty. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.